Barrie Urology Associates

Quick facts

Marketed products

• Oxycodone and acetaminophen combination treatment · Pain Management
  Oxycodone binds to opioid receptors to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.
• Solifenacin succinate treatment · Urology
  Solifenacin succinate is a muscarinic M3 receptor antagonist that reduces involuntary bladder muscle contractions.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Barrie Urology Associates portfolio CI brief
• Barrie Urology Associates pipeline updates RSS